Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | GLA | P06280 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 2/20 | 0.41 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27812372 | 0.81 | DPP4 (0.52) | ALDH1A1MAPTSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL11501462 | 0.80 | SMN1; SMN2 (0.45) | ALDH1A1MAPTSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL28193344 | 0.79 | ALDH1A1 (0.58) | ALDH1A1MAPTSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL7253560 | 0.76 | KMT2A (0.49) | ALDH1A1MAPTSMN1; SMN2LMNACYP2D6 | |
| SCHEMBL27741243 | 0.76 | ALDH1A1 (0.50) | ALDH1A1MAPTSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL27761255 | 0.75 | KMT2A (0.53) | ALDH1A1MAPTSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL9329217 | 0.74 | CES1 (0.39) | ALDH1A1MAPTCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL27335686 | 0.74 | MEN1 (0.51) | ALDH1A1MAPTLMNACYP1A2CYP2D6 | |
| SCHEMBL13382365 | 0.73 | ALDH1A1 (0.57) | ALDH1A1MAPTSMN1; SMN2LMNACYP1A2 | |
| SCHEMBL19609002 | 0.72 | KMT2A (0.53) | ALDH1A1MAPTSMN1; SMN2LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1373250-B1 | VIOLOGEN LINKED ACRIDINE BASED MOLECULE AND PROCESS FOR THE PREPARATION THEREOF | COUNCIL SCIENT IND RES (IN) | 2006-08-30 | — | — | EP | disclosed |
| EP-1373250-A1 | VIOLOGEN LINKED ACRIDINE BASED MOLECULE AND PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-01-02 | — | — | EP | disclosed |
| US-6630481-B2 | Phototherapeutic and catalytic photoactivated DNA cleaving agents | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH OF INDIA (IN) | 2003-10-07 | — | — | US | disclosed |
| US-20030045538-A1 | Viologen linked acridine based molecule and process for the preparation thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH OF INDIA | 2003-03-06 | — | — | US | disclosed |
| WO-2002079191-A1 | VIOLOGEN LINKED ACRIDINE BASED MOLECULE AND PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2002-10-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045538-A1 | Viologen linked acridine based molecule and process for the preparation thereof | UNG, OGG1, MPG | ALDH1A1 438/4885MAPT 4191/4885SMN1; SMN2 4729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.